Hera Diagnostics
Hera Diagnostics is pioneering affordable and accessible healthcare solutions, focusing on modernizing cervical cancer screenings through innovative optical and electrical spectroscopy combined with advanced AI algorithms. Their flagship product, Insta Pap©, aims to provide instantaneous results and improve health services for women globally, regardless of their socioeconomic status. The company is positioned to disrupt traditional cancer screening methods by offering portable and user-friendly diagnostic tools that can reach underserved populations, thereby enhancing early detection and treatment options.
Hera Diagnostics
Hera Diagnostics is pioneering affordable and accessible healthcare solutions, focusing on modernizing cervical cancer screenings through innovative optical and electrical spectroscopy combined with advanced AI algorithms. Their flagship product, Insta Pap©, aims to provide instantaneous results and improve health services for women globally, regardless of their socioeconomic status. The company is positioned to disrupt traditional cancer screening methods by offering portable and user-friendly diagnostic tools that can reach underserved populations, thereby enhancing early detection and treatment options.
TL;DR
Focus: Portable cervical cancer screening using optical + electrical spectroscopy and AI
Founded: 2020
Headcount: Approximately 12 employees
Funding: Seed round closed Dec 2, 2022; total funding reported USD 900,000
Company Overview
Problem Domain
Cervical cancer screening and broader women’s health diagnostics
Founded
2020
Industry
Medical devices; Women's health diagnostics
Funding Track Record
Seed round closed Dec 2, 2022; publicly listed amount obfuscated in some profiles
Investor Signal
“Early-stage capital from angel and strategic investors including Guadalajara Angel Investor Network (GAIN) and Encore Health; launched a Regulation Crowdfunding (Wefunder) campaign”